Coverage & Payment / Diagnostics / Global & Trade / Government & Legislative Affairs / Regulatory Affairs / Small Business

AdvaMed®’s Medical Innovation Agenda for the 119th Congress

AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.

Coverage & Payment / Diagnostics / Global & Trade / Government & Legislative Affairs / Health Access / Legal / Regulatory Affairs / Small Business

The Medical Innovation Agenda for the 119th Congress

AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.

A document titled "The Impact of Tariffs on Patient Access to Medical Technology" features sections discussing the importance of the medtech industry and the negative effects of import tariffs on healthcare costs, supply chains, and patient access. The document is formatted with bullet points and bolded key terms
Coverage & Payment / Emerging Policy Response Resources / Global & Trade / Supply Chain / Tariffs

The Impact of Tariffs on Patient Access to Medical Technology

Tariffs on medtech could disrupt supply chains, increase costs, and delay care. Exemptions are needed to protect hospitals, patients, and innovation.

Washington DC Aerial View
In Person

AdvaMed® Payment Policy Forum

TheAdvaMed® Payment Policy Forum returns May 28–29, 2026 in Washington, D.C., bringing together medtech leaders, reimbursement experts, provider representatives, and policy specialists for two focused days of strategy, insight, and…

Coverage & Payment

AdvaMed® Statement on Final TCET Notice

AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker on the final Transitional Coverage for Emerging Technologies (TCET) notice from the Centers for Medicare and…